These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model. Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735 [TBL] [Abstract][Full Text] [Related]
9. Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility. Malik N; Gunn J; Shepherd L; Crossman DC; Cumberland DC; Holt CM J Invasive Cardiol; 2001 Mar; 13(3):193-201. PubMed ID: 11231644 [TBL] [Abstract][Full Text] [Related]
10. Modification of molecular events in coronary restenosis using coated stents: The Mayo Clinic Approach. Keelan PC; Miyauchi K; Caplice NM; Ashai KH; Schwartz RS Semin Interv Cardiol; 1998; 3(3-4):211-5. PubMed ID: 10406696 [TBL] [Abstract][Full Text] [Related]
11. Drug-eluting balloons for percutaneous coronary interventions. Zimarino M; De Caterina R Thromb Haemost; 2009 Jan; 101(1):9-11. PubMed ID: 19132182 [No Abstract] [Full Text] [Related]
12. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry. Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999 [TBL] [Abstract][Full Text] [Related]
15. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559 [TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis. Carter AJ Catheter Cardiovasc Interv; 2005 Dec; 66(4):496-8. PubMed ID: 16283681 [No Abstract] [Full Text] [Related]
17. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation. Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model. Satzl S; Henn C; Christoph P; Kurz P; Stampfl U; Stampfl S; Thomas F; Radeleff B; Berger I; Grunze M; Richter GM Invest Radiol; 2007 May; 42(5):303-11. PubMed ID: 17414526 [TBL] [Abstract][Full Text] [Related]
19. Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model. Huang Y; Liu X; Wang L; Li S; Verbeken E; De Scheerder I Coron Artery Dis; 2003 Aug; 14(5):401-8. PubMed ID: 12878906 [TBL] [Abstract][Full Text] [Related]
20. Polymer-sirolimus-eluting stents in de novo lesions. Schuler G Herz; 2004 Mar; 29(2):152-61. PubMed ID: 15057437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]